Genomic Study Maps Shared Risk Factors for 14 Psychiatric Disorders
December 14, 2025
Background
Nodular Localized Cutaneous Amyloidosis (NLCA) is one form of the localized type of amyloidosis that affects the skin. NLCA is cutaneous, while systemic amyloidosis is generalized amyloidosis and can involve any organ but not the skin; it mainly involves the dermis. These deposits are amyloid deposits made up of nonfunctional protein fibrils attributed to skin lesions.
Epidemiology
Prevalence: This is one of the eight types of amyloidosis and the rarest type of the disease. It is impossible to get exact statistics because of the rarity of occurrence of this disease.
Age: It mostly affects adults, especially middle-aged adults, although it may happen at any age.
Gender: The findings of the present study do not confirm gender dominance. However, some of the research indicates that the female population is more dominant.
Geographic Variation: This, in general, might give a more responsive geographic impression of the general appearance of the condition; however, trend reports of specific populations in different geographical areas are limited.
Anatomy
Pathophysiology
Amyloid Protein Deposition: Amyloidosis is a disease that occurs with the extracellular deposition of insoluble fibril proteins known as amyloid. There is localized cutaneous amyloidosis condition where only amyloid is deposited locally in human skin. The cutaneous amyloid type, which is most deposited, is generally derived from light chains of immunoglobulins or other proteins.
Fibril Formation: Amyloid proteins transform themselves from a fibril through the process of misfolding. Such fibrils consist of a structure called beta-pleated sheet morphology. They do not degenerate at the hands of proteolytic enzymes, and they retain colour with dyes such as Congo red.
Skin Involvement: In nodular localized cutaneous amyloidosis, these fibrils deposit in the dermis of the skin; the condition is not lethal but uncomfortable. This thickening alters the skin’s contour; it shifts the normal architecture of the tissue with nodules or plaques.
Clinical Manifestation: It occurs clinically as round, well-circumscribed nodular or plaque lesions at the sites of the skin. These lesions are often sited on the trunk or limbs or the arms or legs.
Etiology
Chronic Inflammation or Irritation: Several diseases and conditions can cause localized cutaneous amyloidosis, such as injuries in the skin, mostly frictional injuries, tumors, as well as chronic inflammatory diseases. For instance, chronic lichen planus or other chronic dermatitis are some of the conditions that may be associated with it.
Primary Localized Amyloidosis: For most of the patients, localized cutaneous amyloidosis is a standalone pathology that is not associated with a systemic disease.
Secondary to Systemic Conditions: However, localized cutaneous amyloidosis may be found in conjunction with systemic cutaneous amyloidosis or other diseases, although this seems to be rare.
Idiopathic: Most of the time, the exact cause of the condition and its occurrence is not understood.
Genetics
Prognostic Factors
Extent and Distribution: However, the outcome depends on the size and the number of nodules. Localized forms are favorable when compared to more disseminated forms.
Symptoms and Complications: As a result, NLCA is often asymptomatic, yet it may cause skin changes or other cosmetic complications sometimes. Majority of the therapy focuses on the management of the symptoms of these diseases rather than the treatment of the actual disease.
Treatment Response: This is because patients with NLCA may not necessarily require rigorous treatments by health practitioners. However, their symptoms might be relieved by processes such as cryotherapy, steroidal topical application or even a laser therapy. Some study shows that good management leads to a better result hence reducing on symptoms.
Clinical History
Age Group:
Localized cutaneous amyloidosis is more frequent in middle aged and elderly patient especially nodular localized cutaneous amyloidosis. People of young age get affected with this disease but not very often, however it is not limited to specific age. The condition is diagnosed through biopsy and the amyloid deposit in the skin appear as nodule or as plaque. It can affect a large area of skin; however, the lesions are usually either non-symptomatic or mildly symptomatic.
Physical Examination
Skin Nodules
Location
Colour and Texture
Size and Shape
Distribution
Associated Symptoms
Age group
Associated comorbidity
Primary Systemic Amyloidosis
Chronic Inflammatory Diseases
Idiopathic
Dermatologic Conditions
Associated activity
Acuity of presentation
Onset and Progression: The characteristics of NLCA may be apparent over the months to years of disease in many cases. These nodules or plaques may appear as papules or nodules which are elevated, firm, flesh-coloured or slightly reddish; they may involve upper trunk, main and lower limbs.
Symptoms: Occasionally, the nodules may be felt as itching or tenderness of the skin. The lesion is usually round and is nearly always nodular; it may be single or multiple.
Differential Diagnoses
Dermatofibroma
Keloids
Basal Cell Carcinoma
Squamous Cell Carcinoma
Lipomas
Neurofibromas
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Treatment Paradigm:
Topical Therapies:
Corticosteroids: Topical corticosteroids may be useful as anti-inflammatory and anti-pruritic agents; however, they seem to have limited role in management of amyloid deposits.
Calcineurin Inhibitors: While both tacrolimus and pimecrolimus may be used to treat inflammatory characteristics and pruritus, neither of them will affect the amyloid deposit.
Intralesional Injections:
Corticosteroids: Amyloid deposits show some flattening of nodules and the reduction of manifestations after intralesional triamcinolone injections but cannot remove the amyloid.
Methotrexate: Occasionally used intralesional.
Systemic Therapies:
Systemic Steroids or Immunosuppressants: Since they are not very effective and may have unwanted side effects, these medications are used in minimum amounts.
Oral Retinoids: If the disease proves to be refractory to other treatments, then acitretin or isotretinoin is effective, but their effectiveness is different.
Physical Treatments:
Laser Therapy:
CO2 lasers can be used for nodule removal procedure, and this has other benefits apart from the symptom relief.
Cryotherapy: Probably useful in reducing the size of nodules but rarely used because it is known to cause scarring.
Surgical Excision: Done for small isolated subcutaneous tender nodule or cosmetic reasons only but has a high propensity of relapse.
Emerging and Experimental Therapies:
Biologic Agents: Application of biologic agents in the treatment and prevention of the amyloid deposition process has not been typical of the experimental approach, they have been investigational.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
environmental-modifications-in-treating-nlca
Protecting the Skin:
Avoid Trauma: Taking much care of the skin and ensuring that it is not rubbed or damaged in any way can help decrease the conditions that result in the worsening of the symptoms and deposition of amyloid.
Soft Clothing: Use of soft and loose cloths is preferred such as wearing cotton cloths.
Sun Protection: Application of sunblock creams which are classified as broad-spectrum UV and protective clothing as the UV rays worsens the skin conditions.
Humidity and Moisturization:
Humidifiers: This leads to the requirement of using a humidifier, especially under dry climate conditions, through which skin moisture can be retained.
Avoidance of Irritants:
Mild Soaps and Detergents: Get rid of the skincare products, soaps, and detergents that cause skin rash and replace them with those that have no side effects on the skin.
Avoiding Harsh Chemicals: It is also recommended that the patient not encounter any detergents or chemicals so as not to aggravate the skin condition.
Effectiveness of Intralesional Corticosteroids in treating NLCA
Methotrexate
Initially, the dose is 12.5 mg of methotrexate, then titrated up to 25 mg, 40 mg, and 50 mg. The treatments were initially spaced 2-4 weeks apart to assess whether the patient tolerated methotrexate. Once the tolerance was ascertained, 50-mg injections were given once a week for a duration of 6 months without folic acid. This treatment significantly reduced the size of the lesions treated, and they have remained stable.
role-of-surgical-care-in-treating-nlca
Excisional Surgery:
Nodules are best treated by complete surgical excision of the lesions. This approach is used to clear all amyloid deposits from the body.
Recurrence can develop again after excision; thus, patients should be followed up after the surgery.
Curettage and Electrodessication:
This entails scraping the lesion by curettage and then electrocoagulation, in which the base of the lesion is burnt. It might be less traumatic than a total excision of the tumor.
It is with increased rates of local recurrence when compared with excisional surgery.
Laser Therapy:
The procedures that are common include cosmetic enhancement by carbon dioxide laser or other types of ablative lasers, which are mainly cosmetic.
The treatment uses curative intensity radiotherapy and is often delivered where surgical resection is feasible, but the option has been turned down or has failed.
role-of-management-in-treating-nlca
Diagnosis and Assessment:
Although the diagnosis is not difficult, you need to confirm it through a skin biopsy to establish whether there are amyloid deposits.
Assess the anatomic extent of skin lesions and exclude systemic amyloidosis as the etiology of the patient’s skin lesions.
Symptomatic Treatment:
The treatment of symptoms such as pruritus implies that topical steroids, antihistamines, or calcineurin inhibitors should be employed.
Disease Modulation:
Therapies include administration of intralesional corticosteroids to reduce the size of nodules or topical DMSO treatment.
Systemic cure can be attempted in cases where the patient is unresponsive to topical treatments; Acitretin or cyclophosphamide systemic therapy may be utilized.
Monitoring and Follow-Up:
An outpatient review is done to know whether the same has recurred or progressed in case the patient develops new or worsening lesions.
Systematic assessment of the signs of involvement of other organs during the processes.
Patient Education and Support:
Counselling on the pathology and available options regarding the disease that is non-life threatening on most occasions.
If the person has cosmetic issues, they might need counselling, or if the symptoms are constant for an extended period.
Medication
Nodular cutaneous amyloidosis is effectively treated with intralesional methotrexate – PMC (nih.gov)
Future Trends
References
Nodular Localized Cutaneous Amyloidosis (NLCA) is one form of the localized type of amyloidosis that affects the skin. NLCA is cutaneous, while systemic amyloidosis is generalized amyloidosis and can involve any organ but not the skin; it mainly involves the dermis. These deposits are amyloid deposits made up of nonfunctional protein fibrils attributed to skin lesions.
Prevalence: This is one of the eight types of amyloidosis and the rarest type of the disease. It is impossible to get exact statistics because of the rarity of occurrence of this disease.
Age: It mostly affects adults, especially middle-aged adults, although it may happen at any age.
Gender: The findings of the present study do not confirm gender dominance. However, some of the research indicates that the female population is more dominant.
Geographic Variation: This, in general, might give a more responsive geographic impression of the general appearance of the condition; however, trend reports of specific populations in different geographical areas are limited.
Amyloid Protein Deposition: Amyloidosis is a disease that occurs with the extracellular deposition of insoluble fibril proteins known as amyloid. There is localized cutaneous amyloidosis condition where only amyloid is deposited locally in human skin. The cutaneous amyloid type, which is most deposited, is generally derived from light chains of immunoglobulins or other proteins.
Fibril Formation: Amyloid proteins transform themselves from a fibril through the process of misfolding. Such fibrils consist of a structure called beta-pleated sheet morphology. They do not degenerate at the hands of proteolytic enzymes, and they retain colour with dyes such as Congo red.
Skin Involvement: In nodular localized cutaneous amyloidosis, these fibrils deposit in the dermis of the skin; the condition is not lethal but uncomfortable. This thickening alters the skin’s contour; it shifts the normal architecture of the tissue with nodules or plaques.
Clinical Manifestation: It occurs clinically as round, well-circumscribed nodular or plaque lesions at the sites of the skin. These lesions are often sited on the trunk or limbs or the arms or legs.
Chronic Inflammation or Irritation: Several diseases and conditions can cause localized cutaneous amyloidosis, such as injuries in the skin, mostly frictional injuries, tumors, as well as chronic inflammatory diseases. For instance, chronic lichen planus or other chronic dermatitis are some of the conditions that may be associated with it.
Primary Localized Amyloidosis: For most of the patients, localized cutaneous amyloidosis is a standalone pathology that is not associated with a systemic disease.
Secondary to Systemic Conditions: However, localized cutaneous amyloidosis may be found in conjunction with systemic cutaneous amyloidosis or other diseases, although this seems to be rare.
Idiopathic: Most of the time, the exact cause of the condition and its occurrence is not understood.
Extent and Distribution: However, the outcome depends on the size and the number of nodules. Localized forms are favorable when compared to more disseminated forms.
Symptoms and Complications: As a result, NLCA is often asymptomatic, yet it may cause skin changes or other cosmetic complications sometimes. Majority of the therapy focuses on the management of the symptoms of these diseases rather than the treatment of the actual disease.
Treatment Response: This is because patients with NLCA may not necessarily require rigorous treatments by health practitioners. However, their symptoms might be relieved by processes such as cryotherapy, steroidal topical application or even a laser therapy. Some study shows that good management leads to a better result hence reducing on symptoms.
Age Group:
Localized cutaneous amyloidosis is more frequent in middle aged and elderly patient especially nodular localized cutaneous amyloidosis. People of young age get affected with this disease but not very often, however it is not limited to specific age. The condition is diagnosed through biopsy and the amyloid deposit in the skin appear as nodule or as plaque. It can affect a large area of skin; however, the lesions are usually either non-symptomatic or mildly symptomatic.
Skin Nodules
Location
Colour and Texture
Size and Shape
Distribution
Associated Symptoms
Primary Systemic Amyloidosis
Chronic Inflammatory Diseases
Idiopathic
Dermatologic Conditions
Onset and Progression: The characteristics of NLCA may be apparent over the months to years of disease in many cases. These nodules or plaques may appear as papules or nodules which are elevated, firm, flesh-coloured or slightly reddish; they may involve upper trunk, main and lower limbs.
Symptoms: Occasionally, the nodules may be felt as itching or tenderness of the skin. The lesion is usually round and is nearly always nodular; it may be single or multiple.
Dermatofibroma
Keloids
Basal Cell Carcinoma
Squamous Cell Carcinoma
Lipomas
Neurofibromas
Treatment Paradigm:
Topical Therapies:
Corticosteroids: Topical corticosteroids may be useful as anti-inflammatory and anti-pruritic agents; however, they seem to have limited role in management of amyloid deposits.
Calcineurin Inhibitors: While both tacrolimus and pimecrolimus may be used to treat inflammatory characteristics and pruritus, neither of them will affect the amyloid deposit.
Intralesional Injections:
Corticosteroids: Amyloid deposits show some flattening of nodules and the reduction of manifestations after intralesional triamcinolone injections but cannot remove the amyloid.
Methotrexate: Occasionally used intralesional.
Systemic Therapies:
Systemic Steroids or Immunosuppressants: Since they are not very effective and may have unwanted side effects, these medications are used in minimum amounts.
Oral Retinoids: If the disease proves to be refractory to other treatments, then acitretin or isotretinoin is effective, but their effectiveness is different.
Physical Treatments:
Laser Therapy:
CO2 lasers can be used for nodule removal procedure, and this has other benefits apart from the symptom relief.
Cryotherapy: Probably useful in reducing the size of nodules but rarely used because it is known to cause scarring.
Surgical Excision: Done for small isolated subcutaneous tender nodule or cosmetic reasons only but has a high propensity of relapse.
Emerging and Experimental Therapies:
Biologic Agents: Application of biologic agents in the treatment and prevention of the amyloid deposition process has not been typical of the experimental approach, they have been investigational.
Endocrinology, Metabolism
Protecting the Skin:
Avoid Trauma: Taking much care of the skin and ensuring that it is not rubbed or damaged in any way can help decrease the conditions that result in the worsening of the symptoms and deposition of amyloid.
Soft Clothing: Use of soft and loose cloths is preferred such as wearing cotton cloths.
Sun Protection: Application of sunblock creams which are classified as broad-spectrum UV and protective clothing as the UV rays worsens the skin conditions.
Humidity and Moisturization:
Humidifiers: This leads to the requirement of using a humidifier, especially under dry climate conditions, through which skin moisture can be retained.
Avoidance of Irritants:
Mild Soaps and Detergents: Get rid of the skincare products, soaps, and detergents that cause skin rash and replace them with those that have no side effects on the skin.
Avoiding Harsh Chemicals: It is also recommended that the patient not encounter any detergents or chemicals so as not to aggravate the skin condition.
Endocrinology, Metabolism
Methotrexate
Initially, the dose is 12.5 mg of methotrexate, then titrated up to 25 mg, 40 mg, and 50 mg. The treatments were initially spaced 2-4 weeks apart to assess whether the patient tolerated methotrexate. Once the tolerance was ascertained, 50-mg injections were given once a week for a duration of 6 months without folic acid. This treatment significantly reduced the size of the lesions treated, and they have remained stable.
Endocrinology, Metabolism
Excisional Surgery:
Nodules are best treated by complete surgical excision of the lesions. This approach is used to clear all amyloid deposits from the body.
Recurrence can develop again after excision; thus, patients should be followed up after the surgery.
Curettage and Electrodessication:
This entails scraping the lesion by curettage and then electrocoagulation, in which the base of the lesion is burnt. It might be less traumatic than a total excision of the tumor.
It is with increased rates of local recurrence when compared with excisional surgery.
Laser Therapy:
The procedures that are common include cosmetic enhancement by carbon dioxide laser or other types of ablative lasers, which are mainly cosmetic.
The treatment uses curative intensity radiotherapy and is often delivered where surgical resection is feasible, but the option has been turned down or has failed.
Endocrinology, Metabolism
Diagnosis and Assessment:
Although the diagnosis is not difficult, you need to confirm it through a skin biopsy to establish whether there are amyloid deposits.
Assess the anatomic extent of skin lesions and exclude systemic amyloidosis as the etiology of the patient’s skin lesions.
Symptomatic Treatment:
The treatment of symptoms such as pruritus implies that topical steroids, antihistamines, or calcineurin inhibitors should be employed.
Disease Modulation:
Therapies include administration of intralesional corticosteroids to reduce the size of nodules or topical DMSO treatment.
Systemic cure can be attempted in cases where the patient is unresponsive to topical treatments; Acitretin or cyclophosphamide systemic therapy may be utilized.
Monitoring and Follow-Up:
An outpatient review is done to know whether the same has recurred or progressed in case the patient develops new or worsening lesions.
Systematic assessment of the signs of involvement of other organs during the processes.
Patient Education and Support:
Counselling on the pathology and available options regarding the disease that is non-life threatening on most occasions.
If the person has cosmetic issues, they might need counselling, or if the symptoms are constant for an extended period.
Nodular Localized Cutaneous Amyloidosis (NLCA) is one form of the localized type of amyloidosis that affects the skin. NLCA is cutaneous, while systemic amyloidosis is generalized amyloidosis and can involve any organ but not the skin; it mainly involves the dermis. These deposits are amyloid deposits made up of nonfunctional protein fibrils attributed to skin lesions.
Prevalence: This is one of the eight types of amyloidosis and the rarest type of the disease. It is impossible to get exact statistics because of the rarity of occurrence of this disease.
Age: It mostly affects adults, especially middle-aged adults, although it may happen at any age.
Gender: The findings of the present study do not confirm gender dominance. However, some of the research indicates that the female population is more dominant.
Geographic Variation: This, in general, might give a more responsive geographic impression of the general appearance of the condition; however, trend reports of specific populations in different geographical areas are limited.
Amyloid Protein Deposition: Amyloidosis is a disease that occurs with the extracellular deposition of insoluble fibril proteins known as amyloid. There is localized cutaneous amyloidosis condition where only amyloid is deposited locally in human skin. The cutaneous amyloid type, which is most deposited, is generally derived from light chains of immunoglobulins or other proteins.
Fibril Formation: Amyloid proteins transform themselves from a fibril through the process of misfolding. Such fibrils consist of a structure called beta-pleated sheet morphology. They do not degenerate at the hands of proteolytic enzymes, and they retain colour with dyes such as Congo red.
Skin Involvement: In nodular localized cutaneous amyloidosis, these fibrils deposit in the dermis of the skin; the condition is not lethal but uncomfortable. This thickening alters the skin’s contour; it shifts the normal architecture of the tissue with nodules or plaques.
Clinical Manifestation: It occurs clinically as round, well-circumscribed nodular or plaque lesions at the sites of the skin. These lesions are often sited on the trunk or limbs or the arms or legs.
Chronic Inflammation or Irritation: Several diseases and conditions can cause localized cutaneous amyloidosis, such as injuries in the skin, mostly frictional injuries, tumors, as well as chronic inflammatory diseases. For instance, chronic lichen planus or other chronic dermatitis are some of the conditions that may be associated with it.
Primary Localized Amyloidosis: For most of the patients, localized cutaneous amyloidosis is a standalone pathology that is not associated with a systemic disease.
Secondary to Systemic Conditions: However, localized cutaneous amyloidosis may be found in conjunction with systemic cutaneous amyloidosis or other diseases, although this seems to be rare.
Idiopathic: Most of the time, the exact cause of the condition and its occurrence is not understood.
Extent and Distribution: However, the outcome depends on the size and the number of nodules. Localized forms are favorable when compared to more disseminated forms.
Symptoms and Complications: As a result, NLCA is often asymptomatic, yet it may cause skin changes or other cosmetic complications sometimes. Majority of the therapy focuses on the management of the symptoms of these diseases rather than the treatment of the actual disease.
Treatment Response: This is because patients with NLCA may not necessarily require rigorous treatments by health practitioners. However, their symptoms might be relieved by processes such as cryotherapy, steroidal topical application or even a laser therapy. Some study shows that good management leads to a better result hence reducing on symptoms.
Age Group:
Localized cutaneous amyloidosis is more frequent in middle aged and elderly patient especially nodular localized cutaneous amyloidosis. People of young age get affected with this disease but not very often, however it is not limited to specific age. The condition is diagnosed through biopsy and the amyloid deposit in the skin appear as nodule or as plaque. It can affect a large area of skin; however, the lesions are usually either non-symptomatic or mildly symptomatic.
Skin Nodules
Location
Colour and Texture
Size and Shape
Distribution
Associated Symptoms
Primary Systemic Amyloidosis
Chronic Inflammatory Diseases
Idiopathic
Dermatologic Conditions
Onset and Progression: The characteristics of NLCA may be apparent over the months to years of disease in many cases. These nodules or plaques may appear as papules or nodules which are elevated, firm, flesh-coloured or slightly reddish; they may involve upper trunk, main and lower limbs.
Symptoms: Occasionally, the nodules may be felt as itching or tenderness of the skin. The lesion is usually round and is nearly always nodular; it may be single or multiple.
Dermatofibroma
Keloids
Basal Cell Carcinoma
Squamous Cell Carcinoma
Lipomas
Neurofibromas
Treatment Paradigm:
Topical Therapies:
Corticosteroids: Topical corticosteroids may be useful as anti-inflammatory and anti-pruritic agents; however, they seem to have limited role in management of amyloid deposits.
Calcineurin Inhibitors: While both tacrolimus and pimecrolimus may be used to treat inflammatory characteristics and pruritus, neither of them will affect the amyloid deposit.
Intralesional Injections:
Corticosteroids: Amyloid deposits show some flattening of nodules and the reduction of manifestations after intralesional triamcinolone injections but cannot remove the amyloid.
Methotrexate: Occasionally used intralesional.
Systemic Therapies:
Systemic Steroids or Immunosuppressants: Since they are not very effective and may have unwanted side effects, these medications are used in minimum amounts.
Oral Retinoids: If the disease proves to be refractory to other treatments, then acitretin or isotretinoin is effective, but their effectiveness is different.
Physical Treatments:
Laser Therapy:
CO2 lasers can be used for nodule removal procedure, and this has other benefits apart from the symptom relief.
Cryotherapy: Probably useful in reducing the size of nodules but rarely used because it is known to cause scarring.
Surgical Excision: Done for small isolated subcutaneous tender nodule or cosmetic reasons only but has a high propensity of relapse.
Emerging and Experimental Therapies:
Biologic Agents: Application of biologic agents in the treatment and prevention of the amyloid deposition process has not been typical of the experimental approach, they have been investigational.
Endocrinology, Metabolism
Protecting the Skin:
Avoid Trauma: Taking much care of the skin and ensuring that it is not rubbed or damaged in any way can help decrease the conditions that result in the worsening of the symptoms and deposition of amyloid.
Soft Clothing: Use of soft and loose cloths is preferred such as wearing cotton cloths.
Sun Protection: Application of sunblock creams which are classified as broad-spectrum UV and protective clothing as the UV rays worsens the skin conditions.
Humidity and Moisturization:
Humidifiers: This leads to the requirement of using a humidifier, especially under dry climate conditions, through which skin moisture can be retained.
Avoidance of Irritants:
Mild Soaps and Detergents: Get rid of the skincare products, soaps, and detergents that cause skin rash and replace them with those that have no side effects on the skin.
Avoiding Harsh Chemicals: It is also recommended that the patient not encounter any detergents or chemicals so as not to aggravate the skin condition.
Endocrinology, Metabolism
Methotrexate
Initially, the dose is 12.5 mg of methotrexate, then titrated up to 25 mg, 40 mg, and 50 mg. The treatments were initially spaced 2-4 weeks apart to assess whether the patient tolerated methotrexate. Once the tolerance was ascertained, 50-mg injections were given once a week for a duration of 6 months without folic acid. This treatment significantly reduced the size of the lesions treated, and they have remained stable.
Endocrinology, Metabolism
Excisional Surgery:
Nodules are best treated by complete surgical excision of the lesions. This approach is used to clear all amyloid deposits from the body.
Recurrence can develop again after excision; thus, patients should be followed up after the surgery.
Curettage and Electrodessication:
This entails scraping the lesion by curettage and then electrocoagulation, in which the base of the lesion is burnt. It might be less traumatic than a total excision of the tumor.
It is with increased rates of local recurrence when compared with excisional surgery.
Laser Therapy:
The procedures that are common include cosmetic enhancement by carbon dioxide laser or other types of ablative lasers, which are mainly cosmetic.
The treatment uses curative intensity radiotherapy and is often delivered where surgical resection is feasible, but the option has been turned down or has failed.
Endocrinology, Metabolism
Diagnosis and Assessment:
Although the diagnosis is not difficult, you need to confirm it through a skin biopsy to establish whether there are amyloid deposits.
Assess the anatomic extent of skin lesions and exclude systemic amyloidosis as the etiology of the patient’s skin lesions.
Symptomatic Treatment:
The treatment of symptoms such as pruritus implies that topical steroids, antihistamines, or calcineurin inhibitors should be employed.
Disease Modulation:
Therapies include administration of intralesional corticosteroids to reduce the size of nodules or topical DMSO treatment.
Systemic cure can be attempted in cases where the patient is unresponsive to topical treatments; Acitretin or cyclophosphamide systemic therapy may be utilized.
Monitoring and Follow-Up:
An outpatient review is done to know whether the same has recurred or progressed in case the patient develops new or worsening lesions.
Systematic assessment of the signs of involvement of other organs during the processes.
Patient Education and Support:
Counselling on the pathology and available options regarding the disease that is non-life threatening on most occasions.
If the person has cosmetic issues, they might need counselling, or if the symptoms are constant for an extended period.
Nodular cutaneous amyloidosis is effectively treated with intralesional methotrexate – PMC (nih.gov)

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
